Biotechnology
-
IPO Outlook: ALPX, BMR, ASPI, INTS, PRME
The coming week's IPOs could include offerings from Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR), ASP Isotopes (NASDAQ: ASPI), Intensity...
-
IPO Outlook: ALPX, BMR, CTM
Some of the IPOs slated for the week ahead include Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR) and Castellum (NYSEAMERICAN: CTM).
-
Daily Stock Watch: PRVB Stock Buoyant Following Sanofi Deal
Having just signed a major deal with a top pharma player, Provention Bio (NASDAQ: PRVB) is attracting investors' attention. But is PRCB stock a...
-
Should You Buy Wave Life Sciences Stock?
Wave Life Sciences is leading a new era of precision medicine in which rationally designed oligonucleotides are the key to delivering safer, more...
-
Why Investing in Biopharma Could Boost Your Portfolio
Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable...
-
IPO Outlook: LRE, LBGJ, INTS, PRZO, YGF
Some of the IPOs slated for the week ahead include Lead Real Estate (NASDAQ: LRE), Li Bang International (NASDAQ: LBGJ), Intensity Therapeutics...
-
Daily Stock Watch: VRAX Stock Climbs on Monkeypox Testing News
Virax Biolabs Group Ltd (NASDAQ: VRAX) is a heavy gainer on Tuesday morning after its new monkeypox rapid antigen test kits grabbed investors'...
-
Daily Stock Watch: Is NRBO Stock A Good Investment?
Neurobo Pharmaceuticals (NASDAQ: NRBO) has seen its share price climb on the back of a reverse stock split, but is NRBO stock a good investment?
-
Daily Stock Watch: Is Ardelyx Stock A Buy?
Biopharmaceutical outfit Ardelyx Inc (NASDAQ: ARDX) has recently started selling its first treatment, but is ARDX stock worth backing?
-
Is Regen BioPharma a Good Investment?
Regen BioPharma recently filed a patent related to a mRNA cancer immunotherapeutic vaccine. Does the market growth potential make RGBP a good...
-
Purple Biotech Stock: Should I invest?
Oncology stock Purple Biotech (NASDAQ: PPBT) is developing cancer treatments that address the tumor, along with the tumor microenvironment to...
-
Daily Stock Watch: Castle Biosciences (CSTL) Reports Record Q2
Castle Biosciences Inc (NASDAQ: CSTL) sells cancer diagnostic testing services via Medicare. CSTL stock is rising after positive Q2 earnings results.
-
Is Tiziana Life Sciences Stock a buy?
Tiziana Life Sciences Stock has not proved shareholder-friendly thus far. Can this immunotherapy biotech company turn things around?
-
IPO Outlook: MAIA, MGAM
In this week's preview of upcoming IPOs we take a look at MAIA Biotechnology and Mobile Global Esports.
-
Is Legend Biotech Stock a Solid Investment?
With major backing and a promising lead product candidate, Legend Biotech stock looks like an exciting investment opportunity. But is this life...
-
Daily Stock Watch: SLNO Stock Climbs on FDA Feedback
Soleno Therapeutics has seen its share price rise by more than 10% after dialogue with US regulators. But is SLNO stock a good investment?